Commercial strategy built from operating experience.
Vernon Row was created around a simple idea: companies making major commercialization decisions need more than market research.
The Firm
They need someone who understands how those decisions actually translate into pricing, reimbursement, sales organizations, distribution, customer adoption and revenue.
Vernon Row combines senior commercial operating experience with healthcare market intelligence and modern analytical tools to help diagnostics and MedTech companies make better commercialization decisions.
Vernon Row focuses on the period before significant capital is committed — when the commercial decisions that shape a U.S. launch can still be tested, challenged and refined.
Experience Across
- Diagnostics
- MedTech
- Point-of-care testing
- Commercial strategy
- Market development
- Reimbursement
- Pricing
- Sales leadership
- Distribution
- International market entry
- Product launches
Founder
Brian D. Miller
Founder, Vernon Row
Brian D. Miller is a senior healthcare and diagnostics commercialization executive with experience leading commercial organizations across diagnostics, medical technology and healthcare. His work has included launching regulated diagnostic technologies, building U.S. commercialization strategies, developing customer and channel models, navigating reimbursement economics and translating technical products into practical market strategies.
His experience spans executive commercial leadership across diagnostics and medical technology, from emerging companies preparing for launch to established global healthcare organizations.
His perspective is grounded in operating experience rather than theoretical frameworks — the kind of judgment that comes from being accountable for commercial outcomes, not only for advising on them.
Brian founded Vernon Row to give diagnostics and MedTech companies access to senior commercial judgment at the stage where it matters most: before significant resources are committed to a U.S. launch.
Bring experienced commercial judgment to your U.S. market-entry decision.
If your company is evaluating the United States, tell us where you are in the process.
Assess Your U.S. Opportunity